{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:59:12Z","timestamp":1760385552153},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.clinthera.2017.05.350","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T03:30:15Z","timestamp":1497324615000},"page":"1336-1346","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic\/Pharmacodynamic Analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Beining","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoli","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoguo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.05.350_bib1","first-page":"343","article-title":"Comparative study of ornidazole enantiomers on the toxic and side effects to central nervous system in mice","volume":"39","author":"Sun","year":"2008","journal-title":"J China Pharm Univ"},{"key":"10.1016\/j.clinthera.2017.05.350_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijantimicag.2014.07.027","article-title":"Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria","volume":"44","author":"Hu","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2017.05.350_bib3","first-page":"1500","article-title":"In vitro antibacterial activity of ornidazole against 111 clinical isolates of anaerobes","volume":"28","author":"Li","year":"2008","journal-title":"Acta Univ Med Nanjing"},{"key":"10.1016\/j.clinthera.2017.05.350_bib4","first-page":"454","article-title":"Human tolerability and pharmacokinetic studies of levornidazole by dose escalation","volume":"46","author":"Zhao","year":"2011","journal-title":"Chin Pharm J"},{"key":"10.1016\/j.clinthera.2017.05.350_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2015.12.007","article-title":"Improved pharmacokinetic profile of levornidazole following intravenous infusion of 750mg every 24h compared with 500mg every 12h in healthy Chinese volunteers","volume":"47","author":"Cao","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2017.05.350_bib6","article-title":"In Vitro Anti-Anaerobe Pharmacodynamic and Pharmacokinetic\/Pharmacodynamic Study of Laevo-Ornidazole","author":"Hu","year":"2014","journal-title":"Dissertation, Fudan University"},{"key":"10.1016\/j.clinthera.2017.05.350_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/00498257909042323","article-title":"Metabolic studies of ornidazole in the rat in the dog and in man","volume":"9","author":"Schwartz","year":"1979","journal-title":"Xenobiotica"},{"key":"10.1016\/j.clinthera.2017.05.350_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000221906","article-title":"Comparative pharmacokinetic studies of ornidazole and metronidazole in man","volume":"22","author":"Schwartz","year":"1976","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clinthera.2017.05.350_bib9","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1124\/dmd.113.051235","article-title":"Stereoselective glucuronidation of ornidazole in humans: predominant contribution of UDP-glucuronosyltransferases 1A9 and 2B7","volume":"41","author":"Du","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2017.05.350_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.apsb.2012.01.002","article-title":"Characterization of ornidazole metabolites in human bile after intravenous doses by ultraperformance liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"2","author":"Du","year":"2012","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.clinthera.2017.05.350_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchromb.2014.05.058","article-title":"Quantification of levornidazole and its metabolites in human plasma and urine by ultra-performance liquid chromatography-mass spectrometry","volume":"963","author":"Cao","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817306598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817306598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T22:59:01Z","timestamp":1535756341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817306598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0149291817306598"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.05.350","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic\/Pharmacodynamic Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.05.350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}